| PainCS vs Hwoarang | 71–74 | 48.97% |
| PainCS vs Reina | 64–66 | 49.23% |
| PainCS vs King | 57–65 | 46.72% |
| PainCS vs Paul | 54–66 | 45.00% |
| PainCS vs Kazuya | 59–59 | 50.00% |
| PainCS vs Jin | 59–50 | 54.13% |
| PainCS vs Dragunov | 55–52 | 51.40% |
| PainCS vs Bryan | 47–57 | 45.19% |
| PainCS vs Heihachi | 52–46 | 53.06% |
| PainCS vs Asuka | 49–46 | 51.58% |
| PainCS vs Victor | 42–32 | 56.76% |
| PainCS vs Yoshimitsu | 31–35 | 46.97% |
| PainCS vs Steve | 36–30 | 54.55% |
| PainCS vs Alisa | 21–41 | 33.87% |
| PainCS vs Devil Jin | 31–30 | 50.82% |
| PainCS vs Xiaoyu | 35–22 | 61.40% |
| PainCS vs Lars | 24–30 | 44.44% |
| PainCS vs Lili | 27–25 | 51.92% |
| PainCS vs Feng | 22–27 | 44.90% |
| PainCS vs Jun | 24–25 | 48.98% |
| PainCS vs Eddy | 22–27 | 44.90% |
| PainCS vs Law | 24–24 | 50.00% |
| PainCS vs Leo | 20–27 | 42.55% |
| PainCS vs Nina | 22–22 | 50.00% |
| PainCS vs Lee | 18–25 | 41.86% |
| PainCS vs Azucena | 20–18 | 52.63% |
| PainCS vs Lidia | 22–16 | 57.89% |
| PainCS vs Claudio | 17–20 | 45.95% |
| PainCS vs Clive | 19–18 | 51.35% |
| PainCS vs Jack-8 | 16–18 | 47.06% |
| PainCS vs Shaheen | 17–10 | 62.96% |
| PainCS vs Kuma | 14–12 | 53.85% |
| PainCS vs Leroy | 16–7 | 69.57% |
| PainCS vs Zafina | 11–10 | 52.38% |
| PainCS vs Raven | 9–10 | 47.37% |
| PainCS vs Anna | 6–8 | 42.86% |
| PainCS vs Panda | 2–5 | 28.57% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.